Detalles de la búsqueda
1.
The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-432762
2.
Immediate myeloid depot for SARS-CoV-2 in the human lung
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-489942
3.
A conserved immune trajectory of recovery in hospitalized COVID-19 patients
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-484467
4.
COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and may be modified by dexamethasone
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20248552
5.
Global Absence and Targeting of Protective Immune States in Severe COVID-19.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-359935
6.
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-434529
7.
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22282049
8.
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22273396
Resultados
1 -
8
de 8
1
Próxima >
>>